Abstract
This chapter will describe infectious complications of atopic dermatitis, including bacterial, viral, and fungal infections and the evolving understanding of the relationship between atopic dermatitis and infectious disease. The underlying immunological dysregulation and poor skin barrier function associated with atopic dermatitis not only increases the likelihood of infectious complications, but also lends atopic dermatitis skin vulnerable to flares induced by environmental triggers. Thus, this chapter will also highlight the impact of common external environmental agents on precipitating flares of disease. Lastly, this chapter will discuss complications that can arise from treatments and the association of atopic dermatitis with more serious conditions such as lymphoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sun D, Ong PY. Infectious complications in atopic dermatitis. Immunol Allergy Clin North Am. 2017;37(1):75–93. http://www.ncbi.nlm.nih.gov/pubmed/27886912. Accessed 26 Dec 2016.
Elias PM, Hatano Y, Williams ML. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol. 2008;121:1337–43.
Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol. 2007;33(3):167–77. http://www.ncbi.nlm.nih.gov/pubmed/18163223.
Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–94.
Leung DYM. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009;124(3):494–5. doi:10.1016/j.jaci.2009.07.041.
Ong PY, Leung DYM. Bacterial and viral infections in atopic dermatitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;51(3):329–37. doi:10.1007/s12016-016-8548-5.
Higaki S, et al. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. Int J Dermatol. 1999;38(4):265–9.
Leung DYM, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151–60.
Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol. 1974;90(5):525–30.
Ong PY, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151–60. doi:10.1056/NEJMoa021481.
Novak N, Bieber T, Leung DYM. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003;112(Suppl 6):128–39.
Leung DYM. The role of Staphylococcus aureus in atopic eczema. Acta Derm Venereol. 2008;216:21–7.
Lübbe J. Secondary infections in patients with atopic dermatitis. Am J Clin Dermatol. 2003;4(9):641–54. https://www.scopus.com/inward/record.uri?eid=2-s2.0-.
Boguniewicz M, Leung DYM. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol. 2010;125(1):4–13. doi:10.1016/j.jaci.2009.11.027.
Hung S-H, et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol. 2007;98(1):51–6. http://www.ncbi.nlm.nih.gov/pubmed/17225720.
Gonzalez ME, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol. 2016;75(3):481–493.e8. http://linkinghub.elsevier.com/retrieve/pii/S0190962216302067.
Leung DYM. Infection in atopic dermatitis. Curr Opin Pediatr. 2003;15(4):399–404.
Faergemann J. Atopic dermatitis and fungi. Clin Microbiol Rev. 2002;15(4):545–63.
Williams H, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol. 1999;103(1):125–38.
Sidbury R, Tom WL, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014;71(6):1218–33. doi:10.1016/j.jaad.2014.08.038.
Boguniewicz M, Schmid-Grendelmeier P, Leung DYM. Atopic dermatitis. J Allergy Clin Immunol. 2006;118(1):40–3. http://www.ncbi.nlm.nih.gov/pubmed/16815136.
Sidbury R, Davis DM, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49. doi:10.1016/j.jaad.2014.03.030.
Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32. doi:10.1016/j.jaad.2014.03.023.
Wasserbauer N, Ballow M. Atopic dermatitis. Am J Med. 2009;122(2):121–5. doi:10.1016/j.amjmed.2008.09.014.
Legendre L, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;72(6):992–1002. doi:10.1016/j.jaad.2015.02.1116.
Margolis DJ, et al. Association Between Malignancy and Topical Use of Pimecrolimus. JAMA dermatology. 2015;151(6):594–9. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi? artid=4465068&tool=pmcentrez&rendertype=abstract.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Ashbaugh, A.G., Kwatra, S.G. (2017). Atopic Dermatitis Disease Complications. In: Fortson, E., Feldman, S., Strowd, L. (eds) Management of Atopic Dermatitis. Advances in Experimental Medicine and Biology, vol 1027. Springer, Cham. https://doi.org/10.1007/978-3-319-64804-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-64804-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64803-3
Online ISBN: 978-3-319-64804-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)